Dr. Jeffrey Crawford
Overview
When someone is faced with a diagnosis of lung cancer, they may be going through surgery, radiation treatment, chemotherapy or enrolling in a clinical trial. It’s a very complicated process to understand what’s involved and what may happen next. It’s also hard to hear all the answers if you’re by yourself. We encourage our patients to come with family members and friends and loved ones and particularly to identify one or two main go-to people in terms of care-giving and support. That way we can engage them in the whole process. Just as we have a team taking care of the patient, the patient has a team, too. At Duke, we have the opportunity to engage patients in the very latest treatment approaches, whether it’s a new surgical technique, the latest radiation approach, or some novel chemotherapy, immunology, or targeted therapy, several of which we’ve been developing. Duke provides patients with a real opportunity that they may not have elsewhere.
Dr. Crawford is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma.
His clinical research consists of co-authoring 4 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- POS
- PPO
Locations
20 Duke Medicine Cir, Durham, NC 27710
20 Duke Medicine Cir, Durham, NC 27710
Additional Areas of Focus
Dr. Crawford has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
James Vredenburgh is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Vredenburgh is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Glioma, Astrocytoma, Glioblastoma, Brain Tumor, and Bone Marrow Aspiration.
Duke Cancer Center
I am a medical oncologist who specializes in the treatment of patients with skin cancer. I am part of a team of surgical oncologists, dermatologists, and radiation oncologists who all work together to determine the best treatment approach for each patient. My focus is on treating patients with advanced melanoma, as well as melanoma that is at high risk for recurrence after surgery. We also treat patients with merkel cell carcinoma and advanced basal cell and cutaneous squamous cell carcinoma. We also have a number of clinical trial options available, allowing our patients access to the newest therapies available. Dr. Salama is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Melanoma, Melanoma of the Eye, Metastatic Uveal Melanoma, and Primitive Neuroectodermal Tumor (PNET).
University Of North Carolina At Chapel Hill
Frances Collichio is a Hematologist and an Oncologist in Chapel Hill, North Carolina. Dr. Collichio is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Melanoma, Astrocytoma, Glioblastoma, and Oligodendroglioma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Crawford isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Crawford isDistinguished. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Crawford isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Crawford isDistinguished. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Crawford isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Crawford isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- Adult Soft Tissue SarcomaDr. Crawford isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Bone TumorDr. Crawford isAdvanced. Learn about Bone Tumor.
- Epithelioid SarcomaDr. Crawford isAdvanced. Learn about Epithelioid Sarcoma.
- FibrosarcomaDr. Crawford isAdvanced. Learn about Fibrosarcoma.
- LiposarcomaDr. Crawford isAdvanced. Learn about Liposarcoma.
- MesenchymomaDr. Crawford isAdvanced. Learn about Mesenchymoma.
- Experienced
- Lung NodulesDr. Crawford isExperienced. Learn about Lung Nodules.
- Metastatic Brain TumorDr. Crawford isExperienced. Learn about Metastatic Brain Tumor.
- Neuroendocrine TumorDr. Crawford isExperienced. Learn about Neuroendocrine Tumor.
- PlasmacytomaDr. Crawford isExperienced. Learn about Plasmacytoma.
- Polymorphous Low Grade AdenocarcinomaDr. Crawford isExperienced. Learn about Polymorphous Low Grade Adenocarcinoma.
- Sickle Cell DiseaseDr. Crawford isExperienced. Learn about Sickle Cell Disease.